Sign in
HC

Huntsman CORP (HUN)·Q1 2025 Earnings Summary

Executive Summary

  • Q1 2025 came in soft: revenues $1.410B, adjusted EBITDA $72M, adjusted diluted EPS -$0.11, reflecting muted seasonal uplift, weaker volumes, FX headwinds, and outages; management emphasized “bullwhip” order volatility and elevated uncertainty in core end markets .
  • Results were below S&P Global Wall Street consensus: revenue missed by ~$80M, EBITDA by ~$6M, and EPS was slightly more negative than estimates; management doubled targeted cost savings to $100M and prioritized balance-sheet protection and cash generation (consensus figures marked with asterisk below; values retrieved from S&P Global) .
  • Polyurethanes improved segment EBITDA YoY (+8%) on lower raw materials and fixed costs, but Performance Products (-29%) and Advanced Materials (-16%) deteriorated; corporate loss improved on lower overhead and FX gains .
  • Catalysts ahead: US tariffs and a potential antidumping determination on Chinese MDI could structurally favor domestic producers; Q2 includes Rotterdam restart with an estimated $10M remaining headwind; dividend maintained at $0.25, and a strategic decision on European maleic anhydride expected by summer .

What Went Well and What Went Wrong

  • What Went Well

    • Polyurethanes segment EBITDA rose to $42M (+8% YoY) on lower raw materials and fixed costs and higher volumes, despite unfavorable mix and FX headwinds .
    • Corporate/lIFO/other adjusted EBITDA improved to a loss of $36M from $43M, reflecting lower corporate overhead and FX gains .
    • Liquidity remained robust (~$1.3B combined cash and unused capacity); capex discipline ($36M in Q1) and an FY 2025 capex plan of $180–$190M maintained .
    • Management sees medium-term tailwinds from trade policy: “North American MDI tariffs… may have a greater impact on the Americas; Huntsman produces virtually all of our Americas material in North America.” .
  • What Went Wrong

    • Consolidated revenue fell 4% YoY ($1.410B vs $1.470B); adjusted EBITDA declined to $72M (vs $81M YoY), and adjusted diluted EPS worsened (-$0.11 vs -$0.06 YoY) .
    • Performance Products revenue down 12% and segment EBITDA down 29% YoY, impacted by European demand softness and unplanned outages at Moers, Germany .
    • Advanced Materials revenue down 5% and segment EBITDA down 16% YoY due to lower average selling prices and FX; free cash flow was a $107M use (vs $105M YoY), highlighting working capital drag amid volatile orders .
    • Effective tax rate was 56% (adjusted not meaningful), amplifying the net loss; non-GAAP adjustments included $33M income from litigation affecting comparability .

Financial Results

MetricQ3 2024Q4 2024Q1 2025
Revenue ($USD Billions)$1.540 $1.452 $1.410
Adjusted EBITDA ($USD Millions)$131 $71 $72
Adjusted Diluted EPS ($USD)$0.10 -$0.25 -$0.11
Q1 2025 Actual vs ConsensusActualConsensus*Surprise
Revenue ($USD Billions)$1.410 $1.490*Miss
Adjusted EBITDA ($USD Millions)$72 $78.3*Miss
Adjusted Diluted EPS ($USD)-$0.11 -$0.103*Miss
Values retrieved from S&P Global.
Segment Breakdown (Q1 2025 vs Q1 2024)Q1 2025Q1 2024YoY Change
Polyurethanes Revenue ($USD Millions)$912 $926 -2%
Performance Products Revenue ($USD Millions)$257 $291 -12%
Advanced Materials Revenue ($USD Millions)$249 $261 -5%
Polyurethanes Adjusted EBITDA ($USD Millions)$42 $39 +8%
Performance Products Adjusted EBITDA ($USD Millions)$30 $42 -29%
Advanced Materials Adjusted EBITDA ($USD Millions)$36 $43 -16%
KPIsQ1 2025
Gross Profit ($USD Millions)$201
Operating Income ($USD Millions)$42
Net Cash Used in Operating Activities ($USD Millions)-$71
Free Cash Flow ($USD Millions)-$107
Capital Expenditures ($USD Millions)$36
Net Debt ($USD Millions)$1,620
Total Cash ($USD Millions)$334
Combined Cash + Unused Borrowing Capacity~$1.3B
Effective Tax Rate56%

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
CapexFY 2025~$180–$190M (Q4 guide) ~$180–$190M (reiterated) Maintained
Rotterdam Turnaround ImpactH1 2025~$15M (split $5M Q1, $10M Q2) (prior commentary) ~$15M total; ~$10M in Q2 remaining Maintained timing
DividendQ2 2025N/A$0.25 per share (payable Jun 30; record Jun 13) Announced
Adjusted Effective Tax RateFY 2025~35% (as of Q4 2024) Not meaningful in Q1; no update Withdrawn/uncertain
European Maleic AnhydrideSummer 2025Review initiated Decision by summer (strategic options) Timing affirmed
Cost Savings TargetFY 2025Prior $50MDoubled to $100M (target) Raised

Earnings Call Themes & Trends

TopicPrevious Mentions (Q3 2024, Q4 2024)Current Period (Q1 2025)Trend
Tariffs/MacroTrough conditions, cost focus Detailed MDI tariff/antidumping landscape; US/China trade dynamics; uncertainty post “Liberation Day” Intensifying protectionism; potential structural tailwinds for US production
Supply Chain/Order VolatilityStable volumes; trough persistence “Bullwhip effect” between actual demand and orders causing short-term freezes and inventory reductions Heightened monthly volatility; watch for normalization
MDI Pricing & Pass-throughsLower prices YoY; margin pressure Pursuing price increases; margins may expand via falling raw materials; ~50% pass-through in NA contracts Choppy pricing; potential margin expansion if volumes recover
Europe Industrial PolicyEnergy costs/regulation headwinds Continued frustration with EU policy; footprint optimization ongoing Ongoing restructuring and asset decisions
Segment-Specific EventsPP impacted by outages; AM higher costs PP: Moers unplanned outages; AM: $3M fire-related impact; Rotterdam turnaround Temporary operational headwinds
AI/SemiconductorNot highlightedConroe E‑GRADE® unit expansion for semiconductor-grade amines; positioning for AI/advanced node chips Emerging growth vector

Management Commentary

  • CEO on macro and tariffs: “North American MDI tariffs… may have a greater impact on the Americas. Huntsman produces virtually all of our Americas material in North America… we’re in an ideal location to benefit” .
  • On order volatility: “There is a massive disconnect… between what’s being ordered and what’s being produced… the only parallel… is really 2020” .
  • On pricing and margins: “Objective of our price increases was to expand margins… if we can do that by maintaining price and taking advantage of falling raw material prices, we’ll certainly do that” .
  • On dividend: “The dividend has been something… very close to sacred… we feel very confident… to maintain the dividend” .
  • On maleic Europe: “By the middle part of this year… announce a permanent decision… Europe continues to be flooded with maleic from China and indirectly from Russia via Turkey” .

Q&A Highlights

  • Tariffs/antidumping and MDI imports: Management outlined three “buckets” (Section 301 ~31.5%, new tariffs ~145%, antidumping 3%–500% potential) and the multi-quarter timeline; believes outcomes could structurally favor domestic supply over imports .
  • Pricing and pass-through: Roughly half of NA volume under pass-through; margin recapture possible over 3–6+ months for non-pass-through contracts, with inventory-lag dynamics when raw materials move .
  • Operations: Rotterdam turnaround (~$15M H1 impact; $10M in Q2), Moers outage, ~$3M EV customer fire impact; smaller planned turnarounds in Geismar/Caojing/Conroe relatively modest .
  • Cost actions: Targeted cost savings doubled to $100M, with details forthcoming; footprint rightsizing in spray foam (Canada consolidation to Arlington, TX) and select EU downstream closures .
  • Balance sheet: ~$1.3B liquidity; net leverage elevated on LTM trough EBITDA but maturities are long-dated (‘29/’31/’34); management comfortable given cycle normalization potential .

Estimates Context

MetricQ3 2024 Estimate*Q3 2024 ActualQ4 2024 Estimate*Q4 2024 ActualQ1 2025 Estimate*Q1 2025 Actual
Revenue ($USD Billions)$1.550*$1.540 $1.445*$1.452 $1.490*$1.410
Adjusted EBITDA ($USD Millions)$126.4*$131 $74.4*$71 $78.3*$72
Adjusted Diluted EPS ($USD)$0.099*$0.10 -$0.096*-$0.25 -$0.103*-$0.11
Values retrieved from S&P Global.

Where estimates may need to adjust:

  • Lower near-term revenue/EBITDA on Q2 volume uncertainty, ongoing Rotterdam headwind, and European softness; medium-term upside if tariffs/antidumping structurally reduce imports and volumes normalize .

Key Takeaways for Investors

  • Q1 2025 was softer than expected with broad-based demand caution; near-term trading should focus on order trajectory and inventory normalization into late Q2 .
  • Tariffs and the pending antidumping case on MDI are potential medium-term structural tailwinds for Huntsman’s NA production footprint; monitor ITC/Commerce milestones (prelim by September, final by early 2026 per management’s outline) .
  • Expect ~$10M residual Q2 EBITDA headwind from Rotterdam; watch for restart normalization and any offsets from pricing/raw materials .
  • Segment mix matters: Polyurethanes improving on costs; watch Performance Products recovery post-Moers and Advanced Materials pricing dynamics; FX remains a headwind .
  • Cost discipline and footprint optimization accelerating (target $100M savings); incremental announcements likely as EU decisions and spray-foam consolidation proceed .
  • Dividend maintained ($0.25), supported by liquidity and non-operating cash sources (e.g., Praxair settlement), offering yield support at trough .
  • Strategic review of European maleic anhydride due by summer; decision could improve portfolio quality and capital allocation .